Fleming Pharma steps up radiation drug production
Fleming Pharmaceuticals has ramped up production of ThyroShield, a liquid potassium iodide product indicated for thyroid protection in radiation emergencies, to meet increased domestic and international demand.

ThyroShield is an over-the-counter iodide solution which, when taken orally, saturates the thyroid gland so that radioactive iodine cannot be absorbed. The drug is effective for babies and children, who are most at risk during radiation exposure, according to Fenton, Mo.-based Fleming Pharmaceuticals.

The company has qualified a new potassium iodide supplier, established new agreements with vendors to shorten lead times needed to complete orders for ThyroShield package components and identified production line logistics to fulfill any significant new orders for ThyroShield.